PTPRT and non-small cell lung carcinoma: Similarly, in TCGA NSCLC cohort (TCGA LUAD and LSCC, n = 1053), the PTPRT mutations were associated with poor progression-free survival in NSCLC (log-rank test, P = 0.012; Figure 5(b)).